Neoadjuvant ipilimumab plus nivolumab in locally advanced melanoma: A real-world single-centre retrospective study

Neoadjuvant ipilimumab plus nivolumab in locally advanced melanoma: A real-world single-centre retrospective study

Background: Neoadjuvant immune-checkpoint inhibition (neoICI) with ipilimumab and nivolumab has shown high pathologic response rates as well as a long-lasting relapse-free survival in stage III melanoma patients. However, safety and efficacy data from real-world patients is very limited. Methods: St...

Full description

Saved in:
Bibliographic Details
Main Authors: Patrick Schummer, Valerie Glutsch, Lukas Haug, Mathias Rosenfeldt, Johann Lock, Michael Meir, Agmal Scherzad, Detlef Klein, Matthias Goebeler, Hermann Kneitz, Bastian Schilling, Anja Gesierich
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:EJC Skin Cancer
Subjects:
Melanoma
Immunotherapy
Surgery
Online Access:http://www.sciencedirect.com/science/article/pii/S2772611823000034
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2772611823000034

Similar Items